Submit Manuscript  

Article Details

Decoding Novel Mechanisms and Emerging Therapeutic Strategies in Breast Cancer Resistance


Sadat Shafi, Sana Khan, Farazul Hoda, Faizana Fayaz, Archu Singh, Mohammad Ahmed Khan*, Ruhi Ali, Faheem Hyder Pottoo, Sana Tariq and Abul Kalam Najmi   Pages 1 - 12 ( 12 )


Breast cancer, an intricate and highly heterogeneous disorder, has presently afflicted 2.09 million females globally. Nonetheless, chemoresistance remains a paramount challenge in the treatment of breast cancer. Owing to its assorted nature, the chemoresistant mechanisms of breast cancer still need intensive research. The presently available interventions are inadequate to target chemoresistance, therefore more efficient alternatives are urgently needed to improvise existing therapeutic regimens. A myriad of strategies is being explored, such as cancer stem cells (CSCs), immunotherapy, gene therapy, miRNA drug carriers and combination treatment to surmount chemoresistance. Accumulating evidence suggests that abnormalities related to the biogenesis of miRNAs are associated with breast cancer progression and chemoresistance. Additionally, miRNA has been found to mediate several cellular processes and the key markers of breast cancer. miRNAs thus are a promising option for the diagnosis and treatment of breast cancer. CSCs possess responses to cancer treatment, including epithelial-to-mesenchymal transition (EMT), stimulation of signaling pathways mediating auto-renewal, expression of drug transporters or proteins detoxification. The screening of anticancer therapeutics that target CSCs could be another potential alternate for chemoresistant breast cancer. Nanoparticles as chemotherapeutics carriers including liposome, nanoemulsion, dendrimers, gold nanoparticles, etc put forward the options to have numerous drug or imaging agents for theranostics and combinational therapy. This review summarizes the chemoresistance mechanisms of miRNAs, CSCs as well as most recently documented therapeutic approaches for the treatment of chemoresistance in breast cancer.


Breast cancer, Chemoresistance, Cancer stem cells, Nanoparticles, Immunotherapy, miRNAs


Pharmaceutical medicine, Department of Pharmacology, School of Pharmaceutical Education and Research, Department of Pharmacology, Jamia Hamdard , Department of Pharmacology, Jamia Hamdard , Department of Pharmaceutical Chemistry, DIPSAR, Department of Pharmaceutics, Jamia Hamdard , Department of Pharmacology, Jamia Hamdard , Department of Pharmaceutical Chemistry, DIPSAR, Department of Pharmacology, Imam Abdulrahman Bin Faisal University, Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research , Department of Pharmacology, Jamia Hamdard

Read Full-Text article